These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined Effect of Deceased Donor Macrovesicular and Microvesicular Steatosis on Liver Transplantation Outcomes: Analysis of SRTR Data Between 2010 and 2018. Ayloo S; Molinari M; Pentakota SR Transplant Proc; 2021 Dec; 53(10):2971-2982. PubMed ID: 34740448 [TBL] [Abstract][Full Text] [Related]
4. Safe Use of Right Lobe Live Donor Livers With up to 20% Macrovesicular Steatosis Without Compromising Donor Safety and Recipient Outcome. Bhangui P; Sah J; Choudhary N; Gautam D; Gupta V; Srinivasan T; Rastogi A; Piplani T; Saraf N; Saigal S; Soin A Transplantation; 2020 Feb; 104(2):308-316. PubMed ID: 31283669 [TBL] [Abstract][Full Text] [Related]
5. OPTN/SRTR 2021 Annual Data Report: Liver. Kwong AJ; Ebel NH; Kim WR; Lake JR; Smith JM; Schladt DP; Schnellinger EM; Handarova D; Weiss S; Cafarella M; Snyder JJ; Israni AK; Kasiske BL Am J Transplant; 2023 Feb; 23(2 Suppl 1):S178-S263. PubMed ID: 37132348 [TBL] [Abstract][Full Text] [Related]
6. The role of deceased donor liver biopsy: An analysis of 5449 liver transplant recipients. Patel MS; Mohebali J; Coe TM; Sally M; Groat T; Niemann CU; Malinoski DJ; Vagefi PA Clin Transplant; 2020 May; 34(5):e13835. PubMed ID: 32068301 [TBL] [Abstract][Full Text] [Related]
7. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Limanond P; Raman SS; Lassman C; Sayre J; Ghobrial RM; Busuttil RW; Saab S; Lu DS Radiology; 2004 Jan; 230(1):276-80. PubMed ID: 14695401 [TBL] [Abstract][Full Text] [Related]
8. A contemporary analysis of 20,086 deceased donor liver biopsies. Wang BK; Chen AY; Prasadh J; Desai D; Shubin AD; Raschzok N; MacConmara M; Ivanics T; Cotter T; Hwang C; Shah JA; Mufti A; Vagefi PA; Hanish SI; Patel MS World J Surg; 2024 Feb; 48(2):437-445. PubMed ID: 38310313 [TBL] [Abstract][Full Text] [Related]
10. OPTN/SRTR 2022 Annual Data Report: Liver. Kwong AJ; Kim WR; Lake JR; Schladt DP; Schnellinger EM; Gauntt K; McDermott M; Weiss S; Handarova DK; Snyder JJ; Israni AK Am J Transplant; 2024 Feb; 24(2S1):S176-S265. PubMed ID: 38431359 [TBL] [Abstract][Full Text] [Related]
11. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short. Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio. Rogier J; Roullet S; Cornélis F; Biais M; Quinart A; Revel P; Bioulac-Sage P; Le Bail B Liver Transpl; 2015 May; 21(5):690-5. PubMed ID: 25761371 [TBL] [Abstract][Full Text] [Related]
13. Temporal trends in utilization and outcomes of steatotic donor livers in the United States. Jackson KR; Motter JD; Haugen CE; Holscher C; Long JJ; Massie AB; Philosophe B; Cameron AM; Garonzik-Wang J; Segev DL Am J Transplant; 2020 Mar; 20(3):855-863. PubMed ID: 31608597 [TBL] [Abstract][Full Text] [Related]
14. Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival. Northup PG; Intagliata NM; Davis JPE; Argo CK; Pelletier SJ Transplantation; 2020 Jun; 104(6):1193-1200. PubMed ID: 31577675 [TBL] [Abstract][Full Text] [Related]
15. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival. Frongillo F; Avolio AW; Nure E; Mulè A; Pepe G; Magalini SC; Agnes S Transplant Proc; 2009 May; 41(4):1268-72. PubMed ID: 19460535 [TBL] [Abstract][Full Text] [Related]
16. Use of livers with microvesicular fat safely expands the donor pool. Fishbein TM; Fiel MI; Emre S; Cubukcu O; Guy SR; Schwartz ME; Miller CM; Sheiner PA Transplantation; 1997 Jul; 64(2):248-51. PubMed ID: 9256182 [TBL] [Abstract][Full Text] [Related]
17. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study. Gabrielli M; Moisan F; Vidal M; Duarte I; Jiménez M; Izquierdo G; Domínguez P; Méndez J; Soza A; Benitez C; Pérez R; Arrese M; Guerra J; Jarufe N; Martínez J Ann Hepatol; 2012; 11(6):891-8. PubMed ID: 23109453 [TBL] [Abstract][Full Text] [Related]
18. Impact of donor kidney biopsy on kidney yield and posttransplant outcomes. Wang CJ; Wetmore JB; Wey A; Miller J; Snyder JJ; Israni AK Am J Transplant; 2023 Mar; 23(3):387-392. PubMed ID: 36695677 [TBL] [Abstract][Full Text] [Related]
19. Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016. Haugen CE; Holscher CM; Luo X; Bowring MG; Orandi BJ; Thomas AG; Garonzik-Wang J; Massie AB; Philosophe B; McAdams-DeMarco M; Segev DL JAMA Surg; 2019 May; 154(5):441-449. PubMed ID: 30758494 [TBL] [Abstract][Full Text] [Related]